
Shield Therapeutics: Reassuring 1Q’23 Accrufer prescriptions
Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID). Since its US launch